Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Aeolus files IND for acute radiation syndrome candidate AEOL-10150

Aug. 22, 2014

MediciNova discloses results from phase IIa study of ibudilast in opioid dependence

Aug. 20, 2014

NIPER reports novel PON 1 enzymes

Aug. 14, 2014

Lightlake Therapeutics receives funding for development of intranasal naloxone

Aug. 5, 2014

Evzio auto-injector available in the U.S. for emergency treatment of opioid overdose

July 11, 2014

Presentation of data on Aeolus' AEOL-10150 medical countermeasure

July 4, 2014

Embera's phase I study of EMB-001 to receive funding from Sounds Affects Life

July 4, 2014

Japanese researchers present radiation-induced injury treatments

June 27, 2014

Orexo reports phase III data on Zubsolv for induction of buprenorphine maintenance therapy

June 25, 2014

Bunavail buccal film approved by FDA for opioid dependence

June 11, 2014

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...